Vaccine adjuvants play a critical role in enhancing immune responses, enabling dose-sparing and fewer immunizations, and providing more durable protection. However, in low- and middle-income countries (LMICs), vaccine developers must contend with challenges such as cost restraints, limited cold-chain infrastructure, manufacturing scalability, and programmatic complexity.
Intended for LMIC vaccine manufacturers, this two-day webinar will provide an overview of vaccine adjuvants, highlighting how adjuvants can enhance immune responses and support manufacturers in addressing these region-specific vaccination challenges. Topics will include adjuvant types, immunological principles and mechanisms of action, regulatory considerations, manufacturing challenges, and strategies to improve vaccine efficacy and access.
Participants will gain insights into how optimizing adjuvant use can support local manufacturers in their chemistry, manufacturing, and controls processes; foster innovation; and aid in understanding the mechanism of action and the rationale for selecting appropriate adjuvants.
Dates:
- Part 1: 6-9 AM EDT, May 20, 2026
- Part 2: 6-9 AM EDT, May 21, 2026
Speakers include:
- Lakshmi Khandke, PhD, Senior Program Advisor, Vaccines CMC, Center for Vaccine Innovation and Access, PATH
- Derek O’Hagan, PhD, Head of Vaccine Adjuvants and Delivery Systems, GSK
- Mark Alderson, PhD, CSO and US Site Director, Maxvax Biotechnology
- Julie Jospeh, PhD, Senior Biologist/Evaluator, Health Canada Centre for Vaccines, Clinical Trials, and Biostatistics
- Daniel Fullen, PhD, Lead, R&D Innovations, Center for Epidemic Preparedness Innovations (CEPI)
- Dennis Christensen, PhD, Head of Global Research and Development, Adjuvant Systems, Croda Pharma
- Wolfgang Leitner, DSc, Chief of the Innate immunity Section of the Basic immunology Branch/Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID)
- Jay Evans, PhD, Co-Founder and Chief Scientific & Strategy Officer, Inimmune Corporation and Director of the Center for Translational Medicine, University of Montana
Please register for the webinar here.